Digital Imaging for Hematology Coming Into Focus

Digital Imaging for Hematology Coming Into Focus

The leader in differential imaging for hematology can expect a more crowded market space in the coming years. CellaVision AB commands an intriguing, peripheral IVD market sub-segment aimed at eliminating one of the most costly and time-consuming procedures: the manual differential. The company’s products effectively replace manual microscopy and cell counting with automated systems that use neural networking and algorithms to classify blood cell populations based on image-captured and archived m...


E-Prescriptions Drive Use of Cloud Computing

E-Prescriptions Drive Use of Cloud Computing

The demand for systems that can fill prescriptions electronically is one of the keys behind the use of cloud computing systems in healthcare, according to a report from Kalorama Information. The global market for cloud computing in healthcare is estimated to reach $3.9 billion for 2013, representing 21.1% growth over the 2012 year. The finding was made in Kalorama’s latest report, The World Market for Cloud Computing in Healthcare. http://www.kaloramainformation.com/Cloud-Computing-Healthcare-77...


On the Prospect of CLIA-Waived Differentials

On the Prospect of CLIA-Waived Differentials

Hematology testing such as complete blood counts (CBC) and differentials is customarily the domain of clinical laboratories. Instrument automation and the innovation of compact, streamlined models, however, has made such testing possible outside of the lab. Today’s hematology analyzers range from autoloaded, high-throughput and flow cytometry-capable in the lab to closed-menu, benchtop and ease-of-use at a clinic or physician’s office. While labs in the developing world continue to fuel market g...


Roche Closes 454 But Company Not Out of Next-Gen Yet

Roche Closes 454 But Company Not Out of Next-Gen Yet

In Kalorama’s report, " Next Generation Sequencing Trends ," our survey discovered that while 75% of labs had an Illumina sequencer, less than a third had a Roche brand sequencer and it was not generally part of our surveyed labs’ purchasing plans. Roche’s recent move confirms our findings and admists market reality.

This month, Roche announced the closing its wholly-owned subsidiary 454 Life Sciences and laying off the company’s 130 employees. They will keep making sequencers, however, throug...

  • by bcarlson@marketresearch.com
  • October 17 2013


With Fingers Crossed, Biosimilars Market Expected to Grow

With Fingers Crossed, Biosimilars Market Expected to Grow

It’s not the first prediction that has been made about the market for generic forms of biopharmaceutical drugs, but according to Kalorama Information a multi-billion dollar market for biosimilars will arrive in the next five years. Kalorama Information’s new report, The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon alpha, Monoclonal Antibodies, Others), predicts a market of nearly $5 billion dollars. There’s a reason. Biosimilar development is in almost everyone’s interest -...


Hematology Industry Mapping and Its Boundaries

Hematology Industry Mapping and Its Boundaries

Laboratory hematology is largely synonymous with its leading vendors such as Beckman Coulter and Sysmex. High order volumes among such vendors are ensured through established relationships with premium clients such as care networks, other large healthcare institutions, clinical laboratories, and reference labs. The profile of companies such as Beckman Coulter and Abbott Diagnostics is also higher due to the breadth of their product offering, particularly within the core lab - clinical chemistry,...

  • by esalazar@marketresearch.com
  • October 11 2013


Foodborne Pathogens Don’t Pause during Government Shutdown

Foodborne Pathogens Don’t Pause during Government Shutdown

The current government shutdown has unexpectedly brought food safety to the fore once again in the United States. This week, the U.S. Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) issued an alert for Salmonella in Foster Farms chicken. Per the FSIS’s contingency plans, several activities remain exempt and continue through the shutdown, including the inspection of poultry and poultry products.

The critical nature of food safety - both of domestic and imported food...

  • by bcarlson@marketresearch.com
  • October 9 2013


Opportunity in Brazil IVD Market

Opportunity in Brazil IVD Market

Saying Brazil is large is an understatement. The entire European Union could fit comfortable within the geography of Brazil. The only countries in the world that are larger are Russia, Canada, the People’s Republic of China, and the United States. Its economy is growing and government spending, including healthcare, has been enlarged in recent years. Its population of nearly 200 million people demand services, including preventive testing. IVD is one of the many markets growing in the country. B...

  • by bcarlson@marketresearch.com
  • October 3 2013


Don’t Count Out Capillary Systems Yet

Don’t Count Out Capillary Systems Yet

Despite the adoption of next-generation DNA sequencing (NGS) systems, Kalorama Information says that older capillary DNA sequencing systems remain in labs and are used consistently. More than one out of every four sequencers owned by labs surveyed is still a Sanger or capillary type system, and almost all are made by Life Technologies/Applied Biosystems. And those labs that own them are still employing them at a fairly stable rate. The findings were made in a new Kalorama Information report, “Ne...

  • by bcarlson@marketresearch.com
  • October 1 2013


Cloud Computing in Healthcare A Nearly 4 Billion Dollar Market

Cloud Computing in Healthcare A Nearly 4 Billion Dollar Market

Cloud computing systems, off-site servers that can store information accessible to healthcare organization employees at a different location, are among the healthcare IT products most in demand, according to Kalorama Information. The global market for cloud computing in healthcare is estimated to reach $3.9 billion for 2013, representing 21.1% growth over the 2012 year. The push to adopt a higher level of IT in healthcare, growing government mandates, limitations in digital storage, staffing sho...